Company: BIAF
Filing Date: 2025-09-30
Form Type: 8-K
Source: 0001493152-25-016366
Chunk: 0

Company: bioAffinity Technologies, Inc.
Filing Date: 2025-09-30
Form: 8-K
Item: Item 8.01
Chunk 0
---
Item
8.01. Other Events

The
Company issued a press release announcing the pricing of the Offering on September 29, 2025. A copy of the press release is filed herewith
as Exhibit 99.1 and is incorporated by reference herein.

The
Company issued a press release announcing the closing of the Offering on September 30, 2025. A copy of the press release is filed herewith
as Exhibit 99.2 and is incorporated by reference herein.

As
of the date of this Current Report on Form 8-K, after the closing of the Offering and the exercise of certain Pre-Funded Warrants, there
are 3,100,402 shares
of Common Stock outstanding.

As
previously reported in a Current Report on Form 8-K filed by the Company, on
February 7, 2025, the Company received written notice from the Listing Qualifications Staff (the
“ Staff”) of The Nasdaq Stock Market LLC (“ Nasdaq”) notifying it that for the preceding 30 consecutive business
days (December 23, 2024, through February 6, 2025), our Common Stock did not maintain a minimum closing bid price of $1.00 (“ Minimum
Bid Price Requirement”) per share as required by Nasdaq Listing Rule 5550(a)(2). Therefore, in accordance with Nasdaq Listing Rule
5810(c)(3)(A), the Company was provided 180 calendar days, or until August 6, 2025, to regain compliance with the rule.

As
previously reported in a Current Report on Form 8-K filed by the Company, on May 27, 2025, the Company received written notice from the
Staff stating that the Company was not in compliance with Nasdaq Listing Rule 5550(b)(1) (the “ Continued Listing Equity Requirement”)
because its stockholders’ equity of $1,439,404 as of March 31, 2025, as reported in the Company’s Quarterly Report on Form
10-Q filed with the SEC on May 15, 2025, was below the minimum requirement of $2,500,000. Pursuant to Nasdaq’s Listing Rules, the
Company had 45 calendar days to submit a plan to regain compliance with the Continued Listing Equity
Requirement. On July 14, 2025, the Company submitted its plan to regain compliance with the Continued Listing Equity Requirement. On
August 7, 2025